Skip to main content

Table 2 Characteristics of brain natriuretic peptide (BNP) and N-terminal pro-BNP assays

From: Prognostic value of brain natriuretic peptide in acute pulmonary embolism

Reference

BNP/NT-proBNP

Assay

Manufacturer

Kind of assay

Cutoff, pg/mL

Elevated BNP, percentage

Kucher, et al. [1]

BNP

Fluorescence immunoassay

Biosite (San Diego, USA)

Quantitative

90

43.8

Ten Wolde, et al. [2]

BNP

Immunoradiometric assay

Shionoria (Osaka, Japan)

Quantitative

21.7

33

Pieralli, et al. [3]

BNP

Fluorescence immunoassay

Biosite

Quantitative

527

67

Krüger, et al. [4]

BNP

Immunofluorometric assay

Biosite

Quantitative

90

40

Tulevski, et al. [5]

BNP

Immunoradiometric assay

Shionoria

Quantitative

10

50

Logeart, et al. [6]

BNP

Fluorescence immunoassay

Biosite

Quantitative

100

70

Ray, et al. [7]

BNP

Fluorescence immunoassay

BioMérieux (Marcy l'Etoile, France)

Quantitative

200

43

Pruszczyk, et al. [8]

NT-proBNP

ECLIA

Roche (Basel, Switzerland)

Quantitative

NA

83.5

Kucher, et al. [9]

NT-proBNP

ECLIA

Roche

Quantitative

500

57

Kostrubiec, et al. [10]

NT-proBNP

ECLIA

Roche

Quantitative

600

39

Binder, et al. [11]

NT-proBNP

ECLIA

Roche

Quantitative

1,000

54

Maziere, et al. [12]

NT-proBNP

ECLIA

Roche

Quantitative

1,000

43

  1. ECLIA, enhanced chemiluminescence immunoassay; NA, not applicable; NT-proBNP, N-terminal pro-brain natriuretic peptide. Triage BNP test is manufactured by Biosite (San Diego, USA).